Catalio Capital Management

2020

1

1

Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.

NameTitleBoard Position(s)Contact
George PetrocheilosManaging Partner1
R. Jacob VogelsteinManaging Partner1
Tom V. BrooksGeneral Partner1
Company NameStatusFoundedSectorFunding ($)
ImmunaiActive2019Healthcare, Life Sciences$295M
RoundDateInvestors
Immunai raises $60 million series AFebruary 20216
Investor NameInvestor TypeFoundedPortfolio
Viola VenturesVenture Capital200050
TLV PartnersVenture Capital201534
Schusterman Family InvestmentsFamily Office19878
Duquesne FamilyFamily Office20102
Dexcel PharmaCompany19682

Venture Capital

Investor Type

Sign up for free

  • Save profiles to your list
  • Basic search functionality

Catalio Capital Management

Company NameStatusEmployeesFundingSector
ImmunaiActive137$295MHealthcare, Life Sciences